# Glaxo Operations U.K. Ltd. – FDA Inspection, Jun 2, 2017

Source: https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/650fa308-f844-4b69-aa5d-3e08cca79293
Source feed: FDA_Inspections

> FDA inspection 1014765 of Glaxo Operations U.K. Ltd., June 02, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014765
- Company Name: Glaxo Operations U.K. Ltd.
- Inspection Date: 2017-06-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1211398 - 2023-03-16](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/beeed03d-92cd-4f68-97d4-c6f9a9109c7f)
- FDA Inspection 1209851 - 2023-02-10
- [FDA Inspection 1107134 - 2019-09-17](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/8391bdd5-8330-4bf7-97ff-df96b7424ec8)
- [FDA Inspection 1016930 - 2017-07-04](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/6a8728a5-569f-4a0c-b014-af35693fbfc0)
- FDA Inspection 933676 - 2015-06-23

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/samantha-j-bradley/ba45f64f-07a9-4933-833f-b9b339c57783)
- [Zachary A. Bogorad](https://www.keypedia.com/people/zachary-a-bogorad/ae582dcd-f893-44a5-98bd-0b55f401577b)

Company: https://www.keypedia.com/companies/glaxo-operations-uk-ltd/5c8a39c9-a63a-4574-885a-c16948f20589

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c